Pre-IPO Qyuns Therapeutics (PHIP Updates) - Some Points Worth the Attention
Qyuns is overvalued due to gloomy commercialization outlook.Qyuns may even find it hard to recover the cost of pipeline. Investors could trade and...
282 Views
Pre-IPO Qyuns Therapeutics - Conservative About the Outlook
Qyuns’s pipeline lacks competitiveness, facing fierce competition.Together with bleak internationalization outlook, peak sales have obvious...
257 Views
Qyuns Therapeutics (荃信生物) Pre-IPO: Mixed View on Two Core Products
In this note, we look at fundamentals of Qyuns Therapeutics. We examined the two core products, QX002N and QX005N. We have mixed view on its...
296 Views
ECM Weekly (5th Nov 2023)- Midea, WuxiXDC, Cello, Honasa, Qyuns, Ecopro, Lalatech, Mankind, TWE, VNT
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
391 Views
No more insights